These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20155848)

  • 1. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.
    O'Connor PM; Lapointe TK; Beck PL; Buret AG
    Inflamm Bowel Dis; 2010 Aug; 16(8):1411-20. PubMed ID: 20155848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.
    Balmus IM; Ciobica A; Trifan A; Stanciu C
    Saudi J Gastroenterol; 2016; 22(1):3-17. PubMed ID: 26831601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of intestinal inflammation and cancer.
    Westbrook AM; Szakmary A; Schiestl RH
    Arch Toxicol; 2016 Sep; 90(9):2109-2130. PubMed ID: 27311821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer.
    Danese S; Mantovani A
    Oncogene; 2010 Jun; 29(23):3313-23. PubMed ID: 20400974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis-associated cancer: the role of T cells in tumor development.
    Waldner MJ; Neurath MF
    Semin Immunopathol; 2009 Jul; 31(2):249-56. PubMed ID: 19495757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence.
    Zhu H; Li YR
    Exp Biol Med (Maywood); 2012 May; 237(5):474-80. PubMed ID: 22442342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary.
    Yamada Y; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Yoshida S; Furukawa N; Nagai A; Tanase Y; Tsunemi T; Oi H; Kobayashi H
    Int J Gynecol Cancer; 2011 Oct; 21(7):1200-7. PubMed ID: 21885986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
    Itzkowitz SH; Yio X
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation.
    Svrcek M; Borralho Nunes P; Villanacci V; Beaugerie L; Rogler G; De Hertogh G; Tripathi M; Feakins R;
    J Crohns Colitis; 2018 Nov; 12(12):1486-1498. PubMed ID: 30202940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.
    Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE
    Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of inflammation: production and implication in inflammatory bowel disease.
    Kolios G; Petoumenos C; Nakos A
    Hepatogastroenterology; 1998; 45(23):1601-9. PubMed ID: 9840114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Immune Signaling in Colitis-Associated Cancer.
    Waldner MJ; Neurath MF
    Cell Mol Gastroenterol Hepatol; 2015 Jan; 1(1):6-16. PubMed ID: 28247866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
    Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associated neoplastic disease in inflammatory bowel disease.
    Cendan JC; Behrns KE
    Surg Clin North Am; 2007 Jun; 87(3):659-72. PubMed ID: 17560418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium and inflammatory bowel disease.
    Kudva AK; Shay AE; Prabhu KS
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G71-7. PubMed ID: 26045617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.
    Westbrook AM; Szakmary A; Schiestl RH
    Mutat Res; 2010; 705(1):40-59. PubMed ID: 20298806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.